Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Clinical trials reported no serious adverse events, with mostly mild to moderate side effects such as headache, dry mouth, and insomnia
Daewoong Therapeutics (CEO Bokki Kang), a subsidiary of Daewoong Pharmaceutical, has completed preclinical studies and compiled data for a microneedle patch within the Semaglutide series, a GLP-1 analogue, using its proprietary 'CLOPAM' (Closed-Packed Aeroperssured Microneedle) platform
Though extreme side effects are rare, some patients may experience significant changes in bowel movements
Protein Cell 9 , 659663 (2018)
US$ 27.31
US$ 28.54
US$ 25.04
US$ 21.96
US$ 25.35
